These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6213567)
1. D-Tryptophan-6-luteinizing hormone-releasing hormone in the treatment of normogonadotropic oligoasthenozoospermia. Schwarzstein L; Aparicio NJ; Schally AV Int J Androl; 1982 Apr; 5(2):171-8. PubMed ID: 6213567 [TBL] [Abstract][Full Text] [Related]
2. D-tryptophan-6-LH-RH-at los doses in the treatment of male subfertility. Levalle O; Tropea L; Aparicio N; Guitelman A; Mancini A; Schally AM; Schally V Andrologia; 1981; 13(3):207-11. PubMed ID: 6455942 [TBL] [Abstract][Full Text] [Related]
3. D-leucine-6-luteinizing hormone-releasing hormone ethylamide in the treatment of normogonadotropic oligoasthenospermia. Schwarzstein L; Aparicio NJ; Turner D; De Turner EA; Premoli F; Schally AV Fertil Steril; 1978 Mar; 29(3):332-5. PubMed ID: 346384 [TBL] [Abstract][Full Text] [Related]
4. Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal response. Fauser BC; Rolland R; Dony JM; Corbey RS Andrologia; 1985; 17(2):143-9. PubMed ID: 3923865 [TBL] [Abstract][Full Text] [Related]
5. [Prolonged treatment with LH-RH of 6 men with oligoasthenozoospermia and normogonadotropic idiopathic azoospermia]. Póvoa LC; Dos Santos RR; Schermann J; Comarú Schally AM; Schally AV Reproduccion; 1982; 6(3-4):151-8. PubMed ID: 6818054 [No Abstract] [Full Text] [Related]
6. Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients. Turner D; Turner EA; Aparicio NJ; Schwarzstein L; Coy DH; Schally AV Fertil Steril; 1976 May; 27(5):545-8. PubMed ID: 776707 [TBL] [Abstract][Full Text] [Related]
7. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen. Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237 [TBL] [Abstract][Full Text] [Related]
9. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons. Lewis RW; Dowling KJ; Schally AV Proc Natl Acad Sci U S A; 1985 May; 82(9):2975-9. PubMed ID: 3157995 [TBL] [Abstract][Full Text] [Related]
10. Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia. Gross KM; Matsumoto AM; Berger RE; Bremner WJ Fertil Steril; 1986 Mar; 45(3):392-6. PubMed ID: 3081382 [TBL] [Abstract][Full Text] [Related]
11. Follicle-stimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double-blind trial with gonadotropin-releasing hormone. Crottaz B; Senn A; Reymond MJ; Rey F; Germond M; Gomez F Fertil Steril; 1992 May; 57(5):1034-43. PubMed ID: 1572471 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone. Redding TW; Schally AV Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815 [TBL] [Abstract][Full Text] [Related]
13. Long-term effect of D-Trp6-luteinizing hormone-releasing hormone on testicular size and luteinizing hormone, follicle-stimulating hormone, and testosterone levels in hypothalamic hypogonadotropic males. Laron Z; Dickerman Z; Ben Zeev Z; Prager-Lewin R; Comaru-Schally AM; Schally AV Fertil Steril; 1981 Mar; 35(3):328-31. PubMed ID: 6781940 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH. Schally AV; Redding TW; Comaru-Schally AM Med Oncol Tumor Pharmacother; 1984; 1(2):109-18. PubMed ID: 6242477 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of the gonadotrophins and prolactin in sterile men (the LH-RH + TRH test) (author's transl)]. Boucher D; Hermabessiere J; Grizard G; Doly M; Bruhat M Rev Fr Gynecol Obstet; 1977 Oct; 72(10):631-40, 641-4. PubMed ID: 413178 [TBL] [Abstract][Full Text] [Related]
16. Pituitary and testicular response to hypothalamic LH-releasing hormone (LH-RH) in normal and oligospermic men. Schwarzstein L; Aparicio NJ; Turner D; de Turner EA; Premoli F; Rodriguez A; Schally AV Int J Fertil; 1976; (2):96-102. PubMed ID: 8391 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic use of LH-RH in the infertile man. Schwarzstein L Curr Top Mol Endocrinol; 1976; 3():73-91. PubMed ID: 802660 [No Abstract] [Full Text] [Related]
18. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone. Torres-Aleman I; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096 [TBL] [Abstract][Full Text] [Related]
19. Treatment of idiopathic oligozoospermia with tamoxifen. Brigante C; Motta G; Fusi F; Coletta MP; Busacca M Acta Eur Fertil; 1985; 16(5):361-4. PubMed ID: 3936325 [TBL] [Abstract][Full Text] [Related]
20. The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men. Varma TR; Patel RH Int J Gynaecol Obstet; 1988 Feb; 26(1):121-8. PubMed ID: 2892728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]